Poolbeg Pharma PLC (LON:POLB – Get Free Report) shares traded up 11.3% during mid-day trading on Tuesday . The stock traded as high as GBX 3.56 ($0.05) and last traded at GBX 3.56 ($0.05). 1,516,882 shares were traded during mid-day trading, a decline of 37% from the average session volume of 2,394,207 shares. The stock had previously closed at GBX 3.20 ($0.04).
Poolbeg Pharma Stock Performance
The company’s 50 day moving average price is GBX 2.85 and its 200-day moving average price is GBX 4.42. The company has a market cap of £16.87 million, a price-to-earnings ratio of 0.00 and a beta of 2.11.
Poolbeg Pharma (LON:POLB – Get Free Report) last announced its quarterly earnings data on Tuesday, May 20th. The company reported GBX (1.16) (($0.02)) EPS for the quarter. As a group, sell-side analysts forecast that Poolbeg Pharma PLC will post -0.68 earnings per share for the current year.
About Poolbeg Pharma
Poolbeg Pharma plc is a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs. Poolbeg comprises a strong and growing portfolio of development assets.
Further Reading
- Five stocks we like better than Poolbeg Pharma
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 3 Utilities Stocks With Big Earnings, Balanced Risk
- The How And Why of Investing in Oil Stocks
- NVIDIA Regains Top Spot; FOMO Is Why It Will Continue to Rise
- Stock Sentiment Analysis: How it Works
- Intuit’s AI Boom: Stock Soaring, But Should Investors Hit Pause?
Receive News & Ratings for Poolbeg Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Poolbeg Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
